Yeah it’s a shame the ETF Portfolio DNA APIs seem to have closed, looks like they are favouring enterprise clients now:
We are currently focused on handling enterprise clients. We have decided to discontinue the personal/ professional offering. The data you see is not being updated.
So here’s my portfolio update. I’ve simplified this a bit instead of showing all the ETFs I’ll just list ‘tilts’ which make up 37.29% of total - the rest is basically recreating VRWL using underlying Vanguard regional ETFs. If I remade it now I’d just use 2 ETFs for the global bit: 1 developed and 1 emerging, then I’d add tilts to that to make it more simple.
I’ve made very few changes to the portfolio really: I’ve recently added more EM exposure (with EMIM) and bought separate funds for Turkey and Korea just as contrarian / value bets outside of that I just rebalanced the other Vanguard regional funds to better match VWRL.
| Ticker | Name | Current Weighting | Performance (3M) | Performance (6M) | Performance (9M) |
|---|---|---|---|---|---|
| LON:WLDS | iShares MSCI World Small Cap | 11.41% | 3.45% | 5.27% | 14.93% |
| LON:IWFV | iShares World Value Factor | 11.40% | 2.12% | 2.43% | 16.53% |
| LON:EMIM | iShares MSCI Emerging Markets | 6.21% | -3.82% | ||
| LON:INRG | Clean Energy | 3.33% | 0.08% | -5.63% | -16.70% |
| LON:IKOR | iShares MSCI Korea | 2.40% | -8.29% | ||
| LON:ESPO | VanEck Gaming | 1.68% | -4.91% | -2.28% | -1.79% |
| LON:ITKY | iShares MSCI Turkey | 0.88% | 8.81% |
Generally it’s not been a great 3 months for this - in fact all of my main tilts have underperformed.
China has seriously hurt the EM and I’ve been buying that quite aggressively recently to overweight it and falling rates have hurt Value quite a lot - no plans to change either though.
| Portfolio | Performance (3M) | Performance (6M) | Performance (9M) |
|---|---|---|---|
| Selected ETFs | 2.89% | 6.29% | 11.11% |
| VWRL | 4.25% | 9.20% | 12.79% |